These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26968847)

  • 1. The self-reported use of immunostains and cytogenetic testing in the diagnosis of melanoma by practicing U.S. pathologists of 10 selected states.
    Zhao G; Lee KC; Kwon G; Frederick PD; Onega TL; Piepkorn MW; Knezevich S; Barnhill RL; Elder DE; Elmore JG
    J Cutan Pathol; 2016 Jun; 43(6):492-7. PubMed ID: 26968847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathologist Characteristics Associated With Rendering Higher-Grade Diagnoses for Melanocytic Lesions.
    Kerr KF; Elder DE; Piepkorn MW; Knezevich SR; Eguchi MM; Shucard HL; Reisch LM; Elmore JG; Barnhill RL
    JAMA Dermatol; 2023 Dec; 159(12):1315-1322. PubMed ID: 37938821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between histologic assessment and fluorescence in situ hybridization using MelanoSITE in evaluation of histologically ambiguous melanocytic lesions.
    Zembowicz A; Yang SE; Kafanas A; Lyle SR
    Arch Pathol Lab Med; 2012 Dec; 136(12):1571-9. PubMed ID: 22480223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence behind the use of molecular tests in melanocytic lesions and practice patterns of these tests by dermatopathologists.
    Emanuel PO; Andea AA; Vidal CI; Missall TA; Novoa RA; Bohlke AK; Hughes SR; Hurley MY; Kim J
    J Cutan Pathol; 2018 Nov; 45(11):839-846. PubMed ID: 30039879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical application and limitations of the fluorescence in situ hybridization (FISH) assay in the diagnosis and management of melanocytic lesions: a report of 3 cases.
    Nijhawan RI; Votava HJ; Mariwalla K
    Cutis; 2012 Oct; 90(4):189-95. PubMed ID: 23259206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genome-wide high-resolution array-CGH analysis of cutaneous melanoma and comparison of array-CGH to FISH in diagnostic evaluation.
    Wang L; Rao M; Fang Y; Hameed M; Viale A; Busam K; Jhanwar SC
    J Mol Diagn; 2013 Sep; 15(5):581-91. PubMed ID: 23800576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How concerns and experiences with medical malpractice affect dermatopathologists' perceptions of their diagnostic practices when interpreting cutaneous melanocytic lesions.
    Carney PA; Frederick PD; Reisch LM; Knezevich S; Piepkorn MW; Barnhill RL; Elder DE; Geller BM; Titus L; Weinstock MA; Nelson HD; Elmore JG
    J Am Acad Dermatol; 2016 Feb; 74(2):317-24; quiz 324.e1-8. PubMed ID: 26559597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal copy number analysis in melanoma diagnostics.
    North JP; Vemula SS; Bastian BC
    Methods Mol Biol; 2014; 1102():199-226. PubMed ID: 24258981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics and diagnostic performance of pathologists who enjoy interpreting melanocytic lesions.
    Radick AC; Phipps AI; Piepkorn MW; Nelson HD; Barnhill RL; Elder DE; Reisch LM; Frederick PD; Elmore JG
    Dermatol Online J; 2018 Jun; 24(6):. PubMed ID: 30142708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologists' Use of Second Opinions in Interpretation of Melanocytic Cutaneous Lesions: Policies, Practices, and Perceptions.
    Geller BM; Frederick PD; Knezevich SR; Lott JP; Nelson HD; Titus LJ; Carney PA; Tosteson ANA; Onega TL; Barnhill RL; Weinstock MA; Elder DE; Piepkorn MW; Elmore JG
    Dermatol Surg; 2018 Feb; 44(2):177-185. PubMed ID: 28858936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology of melanocytic tumors.
    Busam KJ
    Semin Diagn Pathol; 2013 Nov; 30(4):362-74. PubMed ID: 24342290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ambiguous melanocytic tumors in a tertiary referral center: the contribution of fluorescence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analyses.
    Tetzlaff MT; Wang WL; Milless TL; Curry JL; Torres-Cabala CA; McLemore MS; Ivan D; Bassett RL; Prieto VG
    Am J Surg Pathol; 2013 Dec; 37(12):1783-96. PubMed ID: 24061523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing comfort level with pediatric skin specimens among dermatopathologists and pediatric pathologists: A national cross-sectional survey.
    Enos T; Hughes C; Kelley S; Mir A; Rakheja D; Vandergriff T
    J Cutan Pathol; 2021 Sep; 48(9):1109-1114. PubMed ID: 33635594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the Melanocytic Pathology Assessment Tool and Hierarchy for Diagnosis (MPATH-Dx) classification scheme for diagnosis of cutaneous melanocytic neoplasms: Results from the International Melanoma Pathology Study Group.
    Lott JP; Elmore JG; Zhao GA; Knezevich SR; Frederick PD; Reisch LM; Chu EY; Cook MG; Duncan LM; Elenitsas R; Gerami P; Landman G; Lowe L; Messina JL; Mihm MC; van den Oord JJ; Rabkin MS; Schmidt B; Shea CR; Yun SJ; Xu GX; Piepkorn MW; Elder DE; Barnhill RL;
    J Am Acad Dermatol; 2016 Aug; 75(2):356-63. PubMed ID: 27189823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
    Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
    Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Digital Whole Slide Imaging in Dermatopathology.
    Onega T; Reisch LM; Frederick PD; Geller BM; Nelson HD; Lott JP; Radick AC; Elder DE; Barnhill RL; Piepkorn MW; Elmore JG
    J Digit Imaging; 2016 Apr; 29(2):243-53. PubMed ID: 26546178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative cytogenetic characterization of primary canine melanocytic lesions using array CGH and fluorescence in situ hybridization.
    Poorman K; Borst L; Moroff S; Roy S; Labelle P; Motsinger-Reif A; Breen M
    Chromosome Res; 2015 Jun; 23(2):171-86. PubMed ID: 25511566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.
    Clemente C; Bettio D; Venci A; Scopsi L; Rao S; Ferrari A; Piris A; Mihm MC
    Pathologica; 2009 Oct; 101(5):169-74. PubMed ID: 20218056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologist characteristics associated with accuracy and reproducibility of melanocytic skin lesion interpretation.
    Elder DE; Piepkorn MW; Barnhill RL; Longton GM; Nelson HD; Knezevich SR; Pepe MS; Carney PA; Titus LJ; Onega T; Tosteson ANA; Weinstock MA; Elmore JG
    J Am Acad Dermatol; 2018 Jul; 79(1):52-59.e5. PubMed ID: 29524584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridisation (FISH) in histologically challenging conjunctival melanocytic lesions.
    Mudhar HS; Smith K; Talley P; Whitworth A; Atkey N; Rennie IG
    Br J Ophthalmol; 2013 Jan; 97(1):40-6. PubMed ID: 23137666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.